MediWound Statistics
Total Valuation
MediWound has a market cap or net worth of $181.09 million. The enterprise value is $144.57 million.
| Market Cap | 181.09M |
| Enterprise Value | 144.57M |
Important Dates
The last earnings date was Wednesday, May 27, 2026, before market open.
| Earnings Date | May 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MediWound has 12.85 million shares outstanding. The number of shares has increased by 14.92% in one year.
| Current Share Class | 12.85M |
| Shares Outstanding | 12.85M |
| Shares Change (YoY) | +14.92% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 2.29% |
| Owned by Institutions (%) | 51.52% |
| Float | 8.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.51 |
| Forward PS | 6.07 |
| PB Ratio | 4.38 |
| P/TBV Ratio | 4.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.20.
| Current Ratio | 2.41 |
| Quick Ratio | 2.19 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -44.83 |
Financial Efficiency
Return on equity (ROE) is -71.82% and return on invested capital (ROIC) is -40.15%.
| Return on Equity (ROE) | -71.82% |
| Return on Assets (ROA) | -23.51% |
| Return on Invested Capital (ROIC) | -40.15% |
| Return on Capital Employed (ROCE) | -48.03% |
| Weighted Average Cost of Capital (WACC) | 5.12% |
| Revenue Per Employee | $119,661 |
| Profits Per Employee | -$215,744 |
| Employee Count | 121 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 2.79 |
Taxes
In the past 12 months, MediWound has paid $147,000 in taxes.
| Income Tax | 147,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.82% in the last 52 weeks. The beta is 0.15, so MediWound's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -33.82% |
| 50-Day Moving Average | 16.23 |
| 200-Day Moving Average | 17.37 |
| Relative Strength Index (RSI) | 36.74 |
| Average Volume (20 Days) | 112,837 |
Short Selling Information
The latest short interest is 1.63 million, so 14.47% of the outstanding shares have been sold short.
| Short Interest | 1.63M |
| Short Previous Month | 1.51M |
| Short % of Shares Out | 14.47% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 17.68 |
Income Statement
In the last 12 months, MediWound had revenue of $14.48 million and -$26.11 million in losses. Loss per share was -$2.19.
| Revenue | 14.48M |
| Gross Profit | 2.84M |
| Operating Income | -28.02M |
| Pretax Income | -25.96M |
| Net Income | -26.11M |
| EBITDA | -27.02M |
| EBIT | -28.02M |
| Loss Per Share | -$2.19 |
Balance Sheet
The company has $44.65 million in cash and $8.13 million in debt, with a net cash position of $36.52 million or $2.84 per share.
| Cash & Cash Equivalents | 44.65M |
| Total Debt | 8.13M |
| Net Cash | 36.52M |
| Net Cash Per Share | $2.84 |
| Equity (Book Value) | 41.42M |
| Book Value Per Share | 3.22 |
| Working Capital | 30.52M |
Cash Flow
In the last 12 months, operating cash flow was -$18.77 million and capital expenditures -$6.37 million, giving a free cash flow of -$25.13 million.
| Operating Cash Flow | -18.77M |
| Capital Expenditures | -6.37M |
| Depreciation & Amortization | 1.01M |
| Net Borrowing | -1.30M |
| Free Cash Flow | -25.13M |
| FCF Per Share | -$1.96 |
Margins
Gross margin is 19.61%, with operating and profit margins of -193.53% and -180.30%.
| Gross Margin | 19.61% |
| Operating Margin | -193.53% |
| Pretax Margin | -179.28% |
| Profit Margin | -180.30% |
| EBITDA Margin | -186.58% |
| EBIT Margin | -193.53% |
| FCF Margin | n/a |
Dividends & Yields
MediWound does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.92% |
| Shareholder Yield | -14.92% |
| Earnings Yield | -14.42% |
| FCF Yield | -13.88% |
Analyst Forecast
The average price target for MediWound is $30.17, which is 114.12% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.17 |
| Price Target Difference | 114.12% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 43.51% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 20, 2022. It was a reverse split with a ratio of 1:7.
| Last Split Date | Dec 20, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |